LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • FDA Approves BioMarin's PALYNZIQ For Adolescents 12 Years Of Age And Older With Phenylketonuria 2/27/2026 9:45:49 PM
  • Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) FY 26 Rev. Estimate To 3348 M From 3394 M 2/24/2026 9:19:19 PM
  • Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) Q4 26 Rev. Estimate To 896.2 M From 855.5 M 2/24/2026 9:19:09 PM
  • Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) Q3 26 Rev. Estimate To 834.2 M From 850.9 M 2/24/2026 9:18:48 PM
  • Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) Q2 26 Rev. Estimate To 832.8 M From 846.3 M 2/24/2026 9:18:37 PM
  • Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) Q1 26 Rev. Estimate To 785.1 M From 842.0 M 2/24/2026 9:18:27 PM
  • Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) FY 26 Estimate To 3.10 From 1.10 2/24/2026 9:18:02 PM
  • Wedbush Is Increasing Biomarin Pharmaceutical Inc. (BMRN) Q4 26 Estimate To 0.95 From 0.24 2/24/2026 9:17:53 PM
  • Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) Q3 26 Estimate To 0.76 From 0.27 2/24/2026 9:17:45 PM
  • Wedbush Is Increasing Biomarin Pharmaceutical Inc. (BMRN) Q2 26 Estimate To 0.75 From 0.29 2/24/2026 9:17:34 PM
  • Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) Q1 26 Estimate To 0.64 From 0.32 2/24/2026 9:17:24 PM
  • William Blair Is Cutting Biomarin Pharmaceutical Inc. (BMRN) FY 26 Rev. Estimate To 3.34 Billion From 3.36 Billion 2/24/2026 8:17:09 AM
  • William Blair Is Cutting Biomarin Pharmaceutical Inc. (BMRN) FY 26 Estimate To 5.06 From 5.15 2/24/2026 8:16:30 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap